SciELO - Scientific Electronic Library Online

 
vol.29 issue4Respiratory Failure: A Definition and Classification ProposalSARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Medicina Interna

Print version ISSN 0872-671X

Abstract

FONSECA, Marta et al. High-Flow Nasal Cannula Oxygen Therapy in A Palliative Care Context at Home, a New Opportunity? A Palliative Care Team Experience. Medicina Interna [online]. 2022, vol.29, n.4, pp.13-18.  Epub Jan 02, 2023. ISSN 0872-671X.  https://doi.org/10.24950/rspmi.647.

Dyspnoea is one of the more common symptoms in advance stages of several diseases and its control is crucial for patient comfort. Supplementary oxygen therapy plays an important role on that. In the last years, the use of high-flow nasal cannula oxygen therapy (HFNC) in palliative care has been developed.

We present three cases of patients accompanied by the Palliative Care Team who used HFNC for dyspnoea control and the team’s effort for organizing domiciliary use of it. All patients showed a better quality of life, in what concerns dyspnoea, and the use of opioid therapy was reduced. The presence of the Palliative Care Team was essential for the pa-tient, family and domiciliary care team’s support.

HFNC seems to be a possible secure and effective resource in the management of respiratory symptoms in the palliative patient, along with pharmacological and non-pharmacological strategies.

Keywords : Dyspnea; Oxygen Inhalation Therapy; Palliative Care..

        · abstract in Portuguese     · text in Portuguese     · Portuguese ( pdf )